PAPILLON BIOSCIENCES
Live / Allowed — Fifth extension granted (statement of use) (as of 08 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97600809
- Mark type
- Word mark
- Filed
- 21 Sept 2022
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Bobby A. Ghajar
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations for the treatment of cancer; vaccines for human use
- Class 042 — Scientific and technological services: Development of nanotechnology-based pharmaceutical preparations for cancer delivery platforms; research and development of pharmaceuticals for the treatment of cancer; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
Owner
- Papillon Biosciences, Inc., Pasadena, CA, US
- Papillon Biosciences, Inc., Pasadena, CA, US
Prosecution history
- 09 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2026 — SOU EXTENSION 5 GRANTED
- 27 Mar 2026 — SOU EXTENSION 5 FILED
- 03 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 4 GRANTED
- 16 Dec 2025 — SOU EXTENSION 4 FILED
- 16 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jun 2025 — SOU EXTENSION 3 GRANTED
- 13 Jun 2025 — SOU EXTENSION 3 FILED
- 13 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2024 — SOU EXTENSION 2 GRANTED